Newsroom


Bioventus Receives Authorization to Proceed Under Investigational New Drug Application for Clinical Trial of Placental Tissue Particulate (PTP-001) for the Treatment of Knee OA

DURHAM, NC – November 18, 2020 – Bioventus, a leader in Solutions For Innovative Healing, received authorization to proceed under its investigational…

Read More

Bioventus Appoints Chris Yamamoto Senior Vice President of Business Development and Strategy

DURHAM, NC – November 16, 2020 – Bioventus, a global leader in Innovations For Active Healing, has appointed Chris Yamamoto as Senior Vice President…

Read More

Bioventus to Provide CVS Caremark with its Portfolio of Preferred Options for Knee Osteoarthritis Patients Seeking Pain Relief

DURHAM, NC – November 10 – Beginning January 1, 2021 Bioventus, a global leader in Innovations For Active Healing, will gain preferred access through…

Read More

Bioventus Reaches Milestone with 2 Million DUROLANE® Treatments Worldwide

DURHAM, NC – September 22, 2020 – Bioventus, a global leader in Innovations For Active Healing, is celebrating a milestone and recognizing more than…

Read More

Bioventus Reports First Use of its SIGNAFUSE Bioactive Bone Graft in Strip Format

DURHAM, NC – September 2, 2020 – Bioventus is sharing results of the first in-patient use of its new SIGNAFUSE Bioactive Bone Graft strips. Rick…

Read More

Bioventus Appoints Katrina Church Chief Compliance Officer

DURHAM, NC – August 24, 2020 – Bioventus, a global leader in orthobiologic solutions, has appointed Katrina Church as its Chief Compliance Officer,…

Read More

Hyaluronic Acid Provides Knee OA Pain Relief with Lower Costs, Fewer Adverse Outcomes vs. Corticosteroids or Knee Arthroplasty

DURHAM, NC – August 13, 2020– Intra-articular hyaluronic acid (IHA) knee osteoarthritis (OA) pain relief treatments had lower total medical care…

Read More

Bioventus Makes $15 Million Equity Investment in CartiHeal with an Agreed Option Structure to Acquire Company Upon Milestone Achievements

KFAR SABA, ISRAEL and DURHAM, NC– July 16, 2020 – CartiHeal, developer of the proprietary Agili™-C implant for the treatment of joint surface lesions…

Read More

Bioventus Receives FDA Clearance of Strip Format of its SIGNAFUSE Bioactive Bone Graft

DURHAM, NC – June 25, 2020 – Bioventus, a global leader in orthobiologic solutions, is launching its SIGNAFUSE Bioactive Bone Graft in a new strip…

Read More

Bioventus Selects Bazis NN as Distributor of DUROLANE in Russia

HOOFDDORP, THE NETHERLANDS – June 15, 2020 – Bioventus, a global leader in orthobiologic solutions, has selected Bazis NN as its authorized…

Read More

Search News


Media Inquiries


Thomas Hill
Director of Corporate Communications
919.474.6715
[email protected]

Download Library


Corporate and Brand Logos
Download Now

Product Images
Download Now